(Q72511231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

placebo-controlled trial

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

Henley KS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Lucey MR

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Merion RM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

McLaren ID

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Crider BA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Mackie DS

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Shieck VL

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Nostrant TT

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Brown KA

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 February 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

366-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

Liver transplantation (1).

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The immunosuppressive properties of new oral prostaglandin E1 analogs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Suppression of acute and chronic inflammation by orally administered prostaglandins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The effect of prostaglandins E1 and E2 on the human erythrocyte as monitored by spin labels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The vasodilator actions of isoprenaline, histamine, prostaglandin E2, glucagon and secretin on the hepatic arterial vascular bed of the dog.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

16,16-Dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Administration of prostaglandin E1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Effect of prostaglandin E in multiple experimental models. IV. Effect on resistance to endotoxin and tumor necrosis factor shock.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Treatment of primary liver graft nonfunction with prostaglandin E1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Regulation of the immune response by prostaglandins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and Interleukins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Biochemical and histopathological correlation in liver transplant: the first 180 days

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210216

7 January 2021

Identifiers

DOI

10.1002/HEP.1840210216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7843707%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference